Emyria Limited Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest, by Mr Greg Hutchinson, was filed 29 May 2026.
Emyria Limited: what insiders have been doing
We have very little insider data for Emyria Limited so far: the most recent filing dates from 29 May 2026. With so few records, no pattern can be drawn yet. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -2.2%Entry A$0.05 · Close at T+90 A$0.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended June 2025 · cache
- 25,580,000 sharesShareASXISIN AU0000073645ASX:2924-03095474-6A1327654Canonical exit: 26 Aug 2026 (T+90)
1 of 1 declaration
About Emyria Limited
Emyria Limited is a company listed on the XASX, focused on the healthcare sector. It specializes in developing innovative therapeutic solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
